Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.
Sinha M, Zhang L, Subudhi S, Chen B, Marquez J, Liu EV, Allaire K, Cheung A, Ng S, Nguyen C, Friedlander TW, Aggarwal R, Spitzer M, Allison JP, Small EJ, Sharma P, Fong L.
Sinha M, et al. Among authors: small ej.
J Immunother Cancer. 2021 May;9(5):e002254. doi: 10.1136/jitc-2020-002254.
J Immunother Cancer. 2021.
PMID: 33986125
Free PMC article.
Clinical Trial.